Regístrese
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Men in the spotlight: A rare case of penile squamous carcinoma associated with h...
Información de la revista
Vol. 39. Núm. 8.
Páginas 566-567 (Octubre 2016)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 39. Núm. 8.
Páginas 566-567 (Octubre 2016)
Letter to the Editor
DOI: 10.1016/j.gastrohep.2016.01.008
Acceso a texto completo
Men in the spotlight: A rare case of penile squamous carcinoma associated with human papillomavirus (HPV) infection in a patient with ulcerative colitis (UC)
Los hombres en el punto de mira: un caso raro de carcinoma escamoso de pene asociado a la infección por virus del papiloma humano (VPH) en un paciente con colitis ulcerosa (CU)
Visitas
300
Lissette Batista, Yamile Zabana
Autor para correspondencia
yzabana@gmail.com

Corresponding author.
, Montserrat Aceituno, Maria Esteve
Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Universitari Mútua Terrassa, Terrassa, Catalonia, Spain
Este artículo ha recibido
300
Visitas
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Dear Editor,

HPV is the most common sexually transmitted infection in the world. HPV 16 and 18 are found to account for 90% of all HPV-related cancers in men. We are reporting a rare case of penile squamous carcinoma associated with HPV infection in a patient with ulcerative colitis and under immunosuppressants (IMMs).

A 72-year-old male patient with a personal history of severe chronic obstructive pulmonary disease was diagnosed with ulcerative colitis in 2007. He achieved initial remission with topical and systemic salicylates. But months later he presented a severe flare that required treatment with corticoids. After that episode he was started on thiopurines for corticoid-dependency. He maintained a long-lasting remission thereafter.

In January 2013 he was diagnosed with penile squamous carcinoma that required glansectomy and urethroplasty. Histological results showed a well-differentiated squamous cell carcinoma, with perineural invasion. Inmunohistochemistry was positive for p16. In situ hybridization confirmed HPV 16/18 positive and HPV 6/11 negative. After the diagnosis of penile cancer he stopped azathioprine and was de-intensified to mesalazine 4g per day, maintaining ulcerative colitis remission. On October 2013, he developed an inguinal lymphadenopathy that was a metastatic squamous cell carcinoma. No adjuvant therapy was decided upon in light of the poor prognosis and comorbidity of the patient. He finally died in June 2014.

HPV is highly prevalent in men and it is related to the development of genital warts, penile intraepithelial neoplasia and invasive penile carcinomas. Approximately 40% of invasive penile carcinomas are attributable to HPV 16/18. There are no previous reports of HPV-related cancers in male patients with IBD taking IMMs. Although a cause–effect relationship with IMMs cannot be demonstrated in this case, long-lasting immunosuppression has been shown to increase the number and persistence of HPV-induced lesions.1

Recently, the Second European evidence-based consensus on the prevention, diagnosis, and management of opportunistic infections in IBD recommended HPV vaccination for females aged 11–14 years before onset of sexual activity. They also recommend routine vaccination of males according to national guidelines.2 Vaccinating boys improves cervical cancer eradication, reduces virus transmission, and contributes to the prevention of HPV-associated diseases in both genders3; therefore more substantial incremental benefits are expected from adding males to vaccination programs.

In the present case we have shown an HPV-positive penile cancer developed under therapeutic immunosuppression with thiopurines. To the best of our knowledge, this association has not been reported before. Male vaccination has been shown to significantly reduce HPV-associated anogenital infection and related lesions in men. Therefore, we believe that HPV surveillance and vaccination programs in IBD should actively take into account the male population.

References
[1]
L.M. Cohen, S.K. Tyring, P. Rády, J.P. Callen.
Human papillomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus.
J Am Acad Dermatol, 26 (1992), pp. 840-845
[2]
J.F. Rahier, F. Magro, C. Abreu, A. Armuzzi, S. Ben-Horin, Y. Chowers, et al.
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
J Crohn's Colitis, 8 (2013), pp. 443-468
[3]
P. Crosignani, A. De Stefani, G.M. Fara, A.M. Isidori, A. Lenzi, C.A. Liverani, et al.
Towards the eradication of HPV infection through universal specific vaccination.
BMC Public Health, 11 (2013), pp. 642
Copyright © 2016. Elsevier España, S.L.U. y AEEH y AEG
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.